MAPK/ERK pathway

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 40: Line 40:
==Targets for phosphorylation by MAPKs==
==Targets for phosphorylation by MAPKs==
===One of the first proteins known to be phosphorylated by ERK was a [[microtubule-associated protein]] (MAP)===
===One of the first proteins known to be phosphorylated by ERK was a [[microtubule-associated protein]] (MAP)===
 +
===Regulation of translation and transcription===
 +
One effect of MAPK activation is to alter the translation of mRNA to proteins.
 +
====MAPK phosphorylates the 40S [[ribosomal protein S6 kinase]] (RSK). RSK phosphorylates ribosomal protein S6.
</StructureSection>
</StructureSection>
== References ==
== References ==
<references/>
<references/>

Revision as of 14:04, 17 February 2022

Glycosylated EGFR (PDB code 3i2t)

Drag the structure with the mouse to rotate

References

  1. Brose MS, Volpe P, Feldman M, Kumar M, Rishi I, Gerrero R, Einhorn E, Herlyn M, Minna J, Nicholson A, Roth JA, Albelda SM, Davies H, Cox C, Brignell G, Stephens P, Futreal PA, Wooster R, Stratton MR, Weber BL. BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res. 2002 Dec 1;62(23):6997-7000. PMID:12460918
  2. Antony R, Emery CM, Sawyer AM, Garraway LA. C-RAF mutations confer resistance to RAF inhibitors. Cancer Res. 2013 Aug 1;73(15):4840-51. doi: 10.1158/0008-5472.CAN-12-4089. Epub, 2013 Jun 4. PMID:23737487 doi:http://dx.doi.org/10.1158/0008-5472.CAN-12-4089

Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky

Personal tools